Jamil Atef Chahrour

Dr. Jamil Atef Chahrour

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2025 in Biomolecules
Verified
Journal Article
Open access
PDF file
Jamil Atef ChahrourJamil Atef Chahrour
Jamil Atef Chahrour
ZBZaher Abdel Baki
Zaher Abdel Baki
DBDalia El Badan
Dalia El Badan
GNGhassan Nasser
Ghassan Nasser
Marc MarescaMarc Maresca
Marc Maresca
AHAkram Hijazi
Akram Hijazi
In recent years, herbal medicines (HMs) have been gaining significant attention as alternative or complementary therapeutic options. This is because synthetic drugs are expensive and have side effects, but also because herbal medicines have a rich content of effective bioactive compounds. These natural agents have been widely investigated for their potential in the prevention and management of chronic diseases including cardiovascular disorders, infections, metabolic disorders, neurological disorders, inflammatory disorders digestive diseases, oxidative stress-related diseases, and diabetes mellitus. In this review, we highlight the roles and impacts of various medicinal plants originating from diverse families, showing their bioactive characteristics, and the mechanisms through which they exert antidiabetic effects by regulating insulin secretion, oxidative stress, glucose uptake, and inflammatory pathways. In contrast to previous reviews, our study highlights the role of plants that are less explored, and integrates recent findings as well as future directions and biotechnological applications in plant-based management of diabetes.

22 October 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Jamil Atef ChahrourJamil Atef Chahrour
Jamil Atef Chahrour
ZBZaher Abdel Baki
Zaher Abdel Baki
DBDalia El Badan
Dalia El Badan
KJKaram Jabbour
Karam Jabbour
GNGhassan Nasser
Ghassan Nasser
AHAkram Hijazi
Akram Hijazi
Diabetes mellitus (DM) is a chronic metabolic disorder characterized by an impaired insulin secretion (or action), leading to persistent hyperglycemia. Such a disease, associated with multiple risk factors, can be broadly classified into two major types: Type 1 and type 2 diabetes. In recent years, herbal medicines (HMs) have been gaining significant attention as alternatives or complementary therapeutic options, owing to their rich content of bioactive compounds. These natural agents have been widely investigated for their potential in the prevention and management of several chronic diseases, including (i) cardiovascular disorders, (ii) infections, and notably (iii) diabetes mellitus. In this present state-of-the art review, we highlight the roles and impacts of various medicinal plants originating from diverse families upon emphasizing their active phytoconstituents, and the mechanisms through which they exert antidiabetic effects. Special emphasis is placed on how these bioactive ingredients can modulate glucose metabolism, enhance insulin sensitivity, and ultimately mitigate complications related to diabetes.

14 May 2026 in Exploration of Neuroscience
Verified
Journal Article
Open access
PDF file
Jamil Atef ChahrourJamil Atef Chahrour
Jamil Atef Chahrour
MRMarwa Rammal
Marwa Rammal
ZBZaher Abdel Baki
Zaher Abdel Baki
AHAkram Hijazi
Akram Hijazi
Thymoquinone (TQ), the main bioactive constituent of Nigella sativa, has gained great attention for its neuroprotective properties, especially for Alzheimer’s disease (AD), which is a progressive neurodegenerative disorder with limited therapeutic options. This review provides several experimental evidence on the effects of TQ in AD models. The evidences indicate that TQ reduces the amyloid-β accumulation, reduces the oxidative stress and neuroinflammation, and improves cognitive and behavioral outcomes. Additionally, TQ should be able to promote the neuronal survival and neurogenesis while reducing biological markers that indicate brain damage or neuron loss. Although these findings clearly highlight and show the promising therapeutic potential of the TQ molecule in the AD, it is important to note that further in-depth studies are still needed to fully understand its underlying molecular mechanisms and to determine its clinical relevance in patients.

13 October 2026 in Italian Journal of Food Safety
Verified
Journal Article
Open access
PDF file
KJKarine Joubrane
Karine Joubrane
ZDZeina Daher
Zeina Daher
AJAdla Jammoul
Adla Jammoul
Jamil Atef ChahrourJamil Atef Chahrour
Jamil Atef Chahrour
AHAkram Hijazi
Akram Hijazi
MHMohammad Hneino
Mohammad Hneino
Antibiotic residues in dairy products and the resulting antibiotic-resistant bacteria represent a major global public health concern. This study evaluated the microbiological safety of 400 dairy samples collected over two consecutive years (2022 and 2023) from 16 dairy residue industries across four governorates in Lebanon. In addition, antibiotic residues were screened from 126 dairy product samples randomly chosen out of the 400. An optimized multi-class method for the identification and quantification of 30 antibiotics was developed using liquid chromatography-mass spectrometry. Results revealed that 48% of the analyzed samples were contaminated with at least one antibiotic residue, among which 33% showed co-occurrence of multiple antibiotic classes. Meanwhile, microbiological assessment of 400 dairy samples collected over 2 years from the same dairies revealed higher levels of contamination with total coliforms, Escherichia coli, and Staphylococcus aureus in Akkawi cheese samples collected during the first year (44%, 32%, and 15%, respectively) compared to those collected the second year (38.8%, 31%, and 0%). Moderate contamination levels were observed in Labneh (strained yogurt) samples collected during both seasons, with yeast (12%; 11%), molds (1.2%; 11%), total coliforms (6%; 11%), and Escherichia coli (3.7%; 11%). On the other hand, comparable levels of non-conformity were observed in yogurt samples across the two years, with contamination by yeast (7.5%; 6.2%), molds (3.75%; 6.2%), total coliforms (26%; 31.2%), E. coli (20%; 21%), and Staphylococcus aureus (1.25%; 0%). Escherichia coli isolates exhibited resistance to tetracycline while being 100% sensitive to ciprofloxacin and nalidixic acid. As for S. aureus isolates, they presented a high sensitivity to tetracyclines, doxycycline, and ciprofloxacin. These findings highlight the importance of implementing and maintaining good hygienic practices within dairy industries. Antimicrobial residues of oxytetracycline, tetracycline, ciprofloxacin, sulfamethazine, and doxycycline were detected at levels below the maximum residue limits.